Klariger

Clarithromycin, the active ingredient in Klariger, is a macrolide antibiotic presented as an oral tablet for oral use. It treats bacterial infections such as community‑acquired pneumonia, acute bacterial sinusitis, bronchitis, skin and soft‑tissue infections, and is used in Helicobacter pylori eradication regimens.

GNH USA supplies Klariger as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Clarithromycin is employed to treat infections caused by susceptible bacteria across several organ systems.

- Community‑acquired pneumonia: eradicates the causative bacterial pathogens and improves respiratory function. - Acute bacterial sinusitis: reduces infection and alleviates sinus congestion and pain. - Acute bacterial bronchitis: clears bacterial involvement and relieves cough. - Skin and soft‑tissue infections: treats susceptible Gram‑positive and some Gram‑negative organisms. - Helicobacter pylori eradication (in combination therapy): contributes to bacterial eradication as part of triple‑therapy regimens.

Clarithromycin may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Nausea - Diarrhea - Abdominal pain - Taste disturbance (metallic taste) - Headache - Vomiting

Serious or Rare Side Effects: - Severe allergic reactions (anaphylaxis, angioedema) - QT interval prolongation and cardiac arrhythmias - Clostridioides difficile‑associated colitis - Hepatic dysfunction (hepatitis, jaundice) - Eosinophilic pneumonia - Stevens‑Johnson syndrome or toxic epidermal necrolysis

Before prescribing Klariger, clinicians should consider several safety measures.

- Assess renal and hepatic function: adjust therapy if impairment is present. - Avoid use in patients with known macrolide hypersensitivity. - Monitor ECG for QT prolongation in individuals with cardiac risk factors. - Use caution when co‑administered with CYP3A4 substrates or inhibitors. - Consider alternative therapy in pregnant or breastfeeding women unless benefits outweigh risks. - Store at room temperature below 25°C: keep in the original pack, protect from moisture.

Clarithromycin interacts with several medicines; some require avoidance while others need monitoring.

Major Interactions (Avoid): - Cisapride: risk of serious cardiac arrhythmias. - Ergot alkaloids: may precipitate ergotism. - CYP3A4‑metabolized statins (e.g., simvastatin): increased risk of myopathy.

Moderate Interactions (Monitor Closely): - Antacids containing aluminum or magnesium: may reduce clarithromycin absorption. - Warfarin: may enhance anticoagulant effect, requiring INR monitoring. - Theophylline: may increase serum theophylline concentrations, risking toxicity.